J Young
Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study
Schäfer J, Bucher H, Battegay M, Furrer H, Cavassini M, Calmy A, Nicca D, Ledergerber B, Bernasconi E, Young J, Swiss HIV Cohort Study. Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2014; 16:3-14.
May 8, 2014Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study
May 8, 2014HIV Med 2014; 16:3-14
Schäfer J, Bucher Hc, Battegay M, Furrer H, Cavassini M, Calmy A, Nicca Dunja, Ledergerber B, Bernasconi E, Young J, Swiss HIV Cohort Study
The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir
Young J, Bucher H, Battegay M, Weber R, Cavassini M, Calmy A, Vernazza P, Furrer H, Bernasconi E, Fux C, Wang Q, Swiss HIV Cohort Study. The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir. HIV Med 2014; 15:505-10.
Mar 18, 2014The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir
Mar 18, 2014HIV Med 2014; 15:505-10
Young J, Bucher H C, Battegay M, Weber R, Cavassini M, Calmy A, Vernazza Pietro, Furrer H, Bernasconi E, Fux C A, Wang Q, Swiss HIV Cohort Study
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Med 2012; 13:387-97.
Jan 18, 2012Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Jan 18, 2012HIV Med 2012; 13:387-97
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca Dunja, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV medicine 2012; 13:387-397.
Jan 18, 2012Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Jan 18, 2012HIV medicine 2012; 13:387-397
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter Rafael, Ledergerber B, Swiss HIV Cohort Study Group
Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
Magenta L, Bernasconi E, Bucher H, Decosterd L, Cavassini M, Evison J, Vernazza P, Hirschel B, Flepp M, Hasse B, Young J, Richter W, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS). Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy. AIDS Res Hum Retroviruses 2010
Nov 22, 2010Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
Nov 22, 2010AIDS Res Hum Retroviruses 2010
Magenta L, Bernasconi E, Bucher H C, Decosterd L A, Cavassini M, Evison J, Vernazza Pietro, Hirschel B, Flepp M, Hasse B, Young J, Richter W O, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS)
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
Young J, Bucher H, Battegay M, Hirschel B, Vernazza P, Bernasconi E, Cavassini M, Fux C, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard H, Scherrer A, for the Swiss HIV Cohort Study. Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study. HIV Med 2010
Oct 18, 2010Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
Oct 18, 2010HIV Med 2010
Young J, Bucher Hc, Battegay M, Hirschel B, Vernazza Pietro, Bernasconi E, Cavassini M, Fux Ca, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard Hf, Scherrer Au, for the Swiss HIV Cohort Study